Journal
JOURNAL OF CLINICAL SLEEP MEDICINE
Volume 18, Issue 2, Pages 587-595Publisher
AMER ACAD SLEEP MEDICINE
DOI: 10.5664/jcsm.9676
Keywords
opioid use disorder; treatment; sleep disturbance; insomnia; chronic pain
Categories
Funding
- National Institute on Drug Abuse [T32 DA007209]
- National Heart, Lung, and Blood Institute [U01 HL150835 01]
- Ashley Addiction Treatment
Ask authors/readers for more resources
This study aimed to investigate the characteristics associated with sleep quality and sleep disturbances in individuals with opioid use disorder (OUD). The study found that sleep quality declined over time and persistent sleep disturbance was correlated with female sex, a greater number of treatment episodes, and positive screens for chronic pain and insomnia. Regular screening for sleep disturbances and chronic pain in OUD patients is recommended, and interventions addressing OUD, sleep disturbance, and chronic pain concurrently are needed.
Study Objectives: Individuals with opioid use disorder (OUD) may experience worsening sleep quality over time, and a subset of individuals may have sleep disturbances that precede opioid use and do not resolve following abstinence. The purpose of the present study was to (1) collect retrospective reports of sleep across the lifespan and (2) identify characteristics associated with persistent sleep disturbance and changes in sleep quality in persons with OUD. Methods: Adults with OUD (n = 154) completed a cross-sectional study assessing current and past sleep disturbance, opioid use history, and chronic pain. Repeated-measures analysis of variance was used to examine changes in retrospectively reported sleep quality, and whether changes varied by screening positive for insomnia and/or chronic pain. Multivariate linear regression analyses were used to identify additional correlates of persistent sleep disturbance. Results: Participants reported that their sleep quality declined over their lifespan. Changes in reported sleep over time varied based on whether the individual screened positive for co-occurring insomnia and/or chronic pain. In regression analyses, female sex (beta = 0.16, P = .042), a greater number of treatment episodes (beta = 0.20, P = .024), and positive screens for chronic pain (beta = 0.19, P = .018) and insomnia (beta=0.22, P = .013) were associated with self-reported persistent sleep disturbance. Only a portion of participants who screened positive for sleep disorders had received a formal diagnosis. Conclusions: OUD treatment providers should routinely screen for co-occurring sleep disturbance and chronic pain. Interventions that treat co-occurring OUD, sleep disturbance, and chronic pain are needed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available